FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection on Social/Behavioral Research

Federal Register notice: FDA sends to OMB an information collection extension entitled Data to Support Social and Behavioral Research as Used by the F...

latest-news-card-1
Federal Register

Comment Period Extended on IRB Proposed Rules

Federal Register notice: FDA extends by two months the comment period on two proposed rules that appeared in the 9/28 Federal Register.

latest-news-card-1
Human Drugs

GSK Narrows Zejula Indication at FDAs Request

GSK says it has complied with an FDA request to restrict the second-line maintenance indication for cancer drug Zejula (niraparib).

latest-news-card-1
Human Drugs

FTC Takes Issue with Jazz Orange Book Listing

The FTC files an amicus brief with the Delaware federal court in the case of Jazz Pharmaceuticals v. Avadel CNS Pharmaceuticals, taking issue with a J...

latest-news-card-1
Human Drugs

Imfinzi/Imjudo OKd for Lung Cancer

FDA approves AstraZenecas Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy for treating adults with Sta...

latest-news-card-1
Medical Devices

DiaSorin Cytomegalovirus Assay for Infants Cleared

FDA clears a DiaSorin 510(k) for its Simplexa Congenital CMV Direct kit, a molecular diagnostic test that detects cytomegalovirus DNA in saliva swab a...

latest-news-card-1
Medical Devices

Device Definition Guidance

FDA publishes a guidance on using definitions for device and counterfeit device.

latest-news-card-1
Human Drugs

ICH Guide on Cell-line Product Viral Safety

FDA seeks comments on a draft guidance entitled Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin Q5...

latest-news-card-1
Human Drugs

Expedited Program Quality Assessment MAPP

The CDER Office of Pharmaceutical Quality publishes a MAPP on its use of regulatory flexibilities to help overcome CMC readiness challenges for drug p...

latest-news-card-1
Federal Register

FDA Determines Regulatory Period for Xcopri

Federal Register notice: FDA determines for patent term extension purposes the regulatory review period for SK Biopharmaceuticals Xcopri (cenobamate)....